-
Matthews latest England World Cup-winner out of Women's Six Nations
-
Race to find port for cruise ship battling deadly rodent virus
-
Celtic's O'Neill says Hearts' rise good for Scottish football
-
Ethiopia and Sudan accuse each other of attacks
-
Injured Mbappe faces backlash over Sardinia trip before Clasico
-
Vodafone to take full ownership of UK mobile operator
-
Stocks advance, oil falls as traders eye US-Iran ceasefire
-
Sabalenka ready to boycott Grand Slams over prize money
-
Boko Haram attack on Chad army base kills at least 24: military, local officials
-
US trade gap widens in March as AI spending boosts imports
-
US threatens 'devastating' response to any Iran attack on shipping
-
Murphy warns snooker hopefuls to 'work harder' to match Chinese stars
-
Race to find port for hantavirus-stricken cruise ship
-
Romanian pro-EU PM loses no-confidence motion
-
Edin Terzic to become Athletic Bilbao coach next season
-
Borthwick backed by RFU to take England to 2027 Rugby World Cup
-
EU hails 'leap forward' in ties with Russia's ally Armenia
-
German car-ramming suspect had mental health problems: reports
-
Pyongyang calling: North Korea shows off own-brand phones
-
Iran warns 'not even started' in Hormuz
-
World body in dark over allegations against China badminton chief
-
Asian stocks drop amid fears over US-Iran ceasefire
-
China fireworks factory explosion kills 26, injures 61
-
China hails 'our era' as Wu Yize's world snooker triumph goes viral
-
Ex-model accuses French scout of grooming her for Epstein
-
Timberwolves eclipse Spurs as Knicks rout Sixers
-
Taiwan leader says island has 'right to engage with the world'
-
Yoko says oh no to 'John Lemon' beer
-
Bayern's Kompany promises repeat fireworks in PSG Champions League semi
-
A coaching great? Luis Enrique has PSG on brink of another Champions League final
-
Top five moments from the Met Gala
-
Brunson leads Knicks in rout of Sixers
-
Retiring great Sophie Devine wants New Zealand back playing Tests
-
Ukraine pressures Russia as midnight ceasefire looms
-
Stocks sink amid fears over US-Iran ceasefire
-
G7 trade ministers set to meet but not discuss latest US tariff threat
-
Sherlock Holmes fans recreate fateful duel at Swiss falls
-
Premier League losses soar for clubs locked in 'arms race'
-
'Spreading like wildfire': Fiji grapples with soaring HIV cases
-
For Israel's Circassians, food and language sustain an ancient heritage
-
'Super El Nino' raises fears for Asia reeling from Middle East conflict
-
Trouble in paradise: Colombia tourist jewel plagued by violence
-
Death toll in Brazil small plane crash rises to three
-
Pulitzers honor damning coverage of Trump and his policies
-
Lawline Exits Beta and Launches Full AI Legal Platform for Businesses and Individuals
-
Digi Power X Signs AI Colocation Agreement with Leading AI Compute Company for 40 MW Data Center in Columbiana, Alabama
-
Camino Appointments Senior Management to Build and Operate the Puquios Copper Mine in Chile and for Corporate Development
-
LA fire suspect had grudge against wealthy: prosecutors
-
US-Iran ceasefire on brink as UAE reports attacks
-
Stars shine at Met Gala, fashion's biggest night
Ozempic Meals? Restaurants shrink portions to match bite-sized hunger
A self-described foodie, social butterfly and New Yorker for 20 years, Lina Axmacher has long loved exploring the city's famed restaurant culture.
Then she started Ozempic.
She lost her appetite -- "my desire for cocktails and desserts and anything sweet" -- and also more than 20 pounds (9.1 kilograms) in less than two months.
But "I still wanted to maintain my social lifestyle, and I still wanted to be included in dinners," the Swedish 41-year-old who works in the tequila industry told AFP.
One of her favorite restaurants, Manhattan's Le Petit Village, made that easier: it's among the dining establishments in the city offering smaller portions at lower prices, as the prevalence of medications that reduce hunger like Ozempic grows.
The West Village restaurant decided to shrink a corner of its brunch menu, including French toast and a smoked salmon tartine, not least to accommodate diners on GLP-1s who want to go out but can't eat much.
Approximately one in eight American adults are currently taking drugs from the class of GLP-1 agonists that are increasingly popular for weight loss, according to a November poll by the non-profit health policy tracker KFF.
And one in five say they've taken the medications whose brand names include Ozempic and Wegovy -- which are also prescribed to manage chronic conditions like diabetes -- at some point.
On Monday, Danish pharmaceutical giant Novo Nordisk announced US authorities had approved Wegovy to be administered in pill form for weight loss, potentially making it even more accessible.
Some in the restaurant industry are taking note.
"I was going out and seeing people eat a lot less and take one bite of their food and one sip of their drink and that was it," said Aristotle Hatzigeorgiou, who owns Clinton Hall, which has five locations across New York.
And on top of that, much of the dishes his kitchens prepared ended up in the trash -- "a mass amount of waste," he said.
So he developed the "teeny-weeny mini meal" -- for $8, diners get a bite-sized burger, a small portion of fries and their choice of a 3-oz beer, martini or glass of wine.
It's a stark contrast to some of the beer hall's other offerings, which include a "doughnut grilled cheese" and a "fondue burger" (they are what they sound like.)
But the mini-meal has proven a hit, Hatzigeorgiou said, not only for those dropping weight but for those cutting costs.
"I think people are definitely strapped with rents going up and inflation," said the restaurant owner.
Offering "a cheaper option to come out," he said, has "been working."
- 'Vast human experiment' -
For now, GLP-1s for weight loss purposes remain too expensive for many Americans.
But experts expect that will shift; even US President Donald Trump has promised affordable options.
And researchers are starting to examine how wider GLP-1 use is shaking cultural connections to food.
"Food is your enemy, instead of your great pleasure in life? I mean, that's very different," Marion Nestle, a professor emerita of nutrition at New York University, told AFP in an interview. "I think the jury is out on all of it."
Side effects of GLP-1s can include unpleasant gastrointestinal issues, but for some people, Nestle said, the medications have proven "miraculous."
The nutritionist said it's far too soon to have a grasp on long-term impact, physiologically or socioculturally: "It's a vast human experiment."
Axmacher told AFP she's taken Ozempic on and off.
When she first decided to take a break, "I was ready to feel like I could enjoy life a little bit more again."
"I do enjoy the sense of hunger and satisfaction when I get to eat something I'm in the mood for," she said, adding that on Ozempic, "I missed that."
But using the medication also helped her develop positive and sustainable habits, she said: Axmacher cut down on alcohol, exercised more, and focused on eating enough protein.
Ozempic or not, a trend of smaller restaurant dishes in the wake of America's 1990s-2000s Super Size Era can only be positive, Nestle said.
Le Petit Village management told AFP they're considering expanding their menu of half-sized portions to dinner service, and Clinton Hall is working on developing a mini-meal featuring chicken.
Some customers, Hatzigeorgiou said, have noted that "this is what meals used to look like."
"We think it's something different, but maybe it's not so different," he said with a chuckle. "Maybe it's the right-sized meal."
E.Paulino--PC